Clinical Trials and Research

Clinical trials are essential for advancing IBM treatment. Current areas of active research include:

  • Rapamycin (Sirolimus): mTOR inhibitor enhancing autophagy to clear protein aggregates
  • BCG Vaccine: Immunomodulatory effects being studied
  • Anti-amyloid therapies: Targeting the beta-amyloid hypothesis
  • Stem cell therapies: Mesenchymal stem cells for muscle regeneration
  • Gene therapy: Approaches targeting specific genetic variants
MSU-Funded IBM ResearchMyositis Support and Understanding (MSU) has been funding IBM-focused research grants since 2022, including biosensic wearables (KU/Dr. Dimachkie), falls and fractures (UT Tyler), mitochondria-myo transfer research, and a dysphagia awareness series.

Support Groups

Finding Specialists

  • TMA Find a Doctor — Searchable directory of myositis specialists
  • Major centers: Mayo Clinic, Cleveland Clinic, Johns Hopkins, Massachusetts General, UCSF
  • Telemedicine: Many specialists now offer virtual consultations
Travel for expertiseIBM is rare enough that most general neurologists see very few cases. It's worth traveling to see a specialist experienced with IBM. TMA and MSU can help identify them.

Patient Voices and Personal Stories

Recommended Reading

Additional Resources

MSU Financial Assistance ProgramMSU provides financial assistance for IBM patients including travel expenses for transfer surgery and expense deferment for mobility devices. They also produce a Burden of Care Study with a Resource Toolkit for patients and care partners on emotional coping.

Key Researchers and Institutions

  • Dr. Marinos Dalakas (Thomas Jefferson University) — Pioneer in IBM research; established IVIg efficacy
  • Dr. Steven Greenberg (Brigham and Women's Hospital/Harvard) — Leading researcher on IBM pathogenesis
  • Dr. Conrad Weihl (Washington University) — Clinical features research
  • Dr. Julie Paik (Johns Hopkins University) — Clinical management
  • Dr. Pedro Machado (University College London) — Sporadic IBM research
  • Dr. Vanda Askanas and Dr. Walter Engel (USC) — Pioneered the degenerative/amyloid hypothesis
  • Mayo Clinic — Major center for IBM diagnosis and research
  • Johns Hopkins Myositis Center — Clinical care and research